View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-0978
ICR Reference No:
202007-0920-014
Status:
Historical Active
Previous ICR Reference No:
202006-0920-015
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-0978-20QT
Title:
Emerging Infections Program
Type of Information Collection:
No material or nonsubstantive change to a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved with change
Conclusion Date:
07/31/2020
Retrieve Notice of Action (NOA)
Date Received in OIRA:
07/29/2020
Terms of Clearance:
Previous terms continue: OMB is approving this information collection request for a period of three years during which time CDC will request approval to extend or revise the collection if the agency seeks to continue the information collection activity beyond the period approved under this action. Similarly, any changes to EIP as a result of ETEC pilot will be submitted for review and approval prior to fielding the data collection. Finally, approval is consistent with the understanding that CDC will continue to add language to its website and reports that clearly caveats the interpretation of longitudinal trends due to changes in the number and characteristics of participating hospitals
Inventory as of this Action
Requested
Previously Approved
Expiration Date
04/30/2022
04/30/2022
04/30/2022
Responses
99,955
0
138,735
Time Burden (Hours)
39,673
0
40,816
Cost Burden (Dollars)
0
0
0
Abstract:
The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies. This is a request for a non-substantive change. Requested changes represent minor modifications to already-approved instruments to include a limited number of data elements pertaining to COVID-19.
Authorizing Statute(s):
US Code:
42 USC 301
Name of Law: Public Health Service Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
83 FR 57488
11/15/2018
30-day Notice:
Federal Register Citation:
Citation Date:
84 FR 5685
02/22/2019
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
32
IC Title
Form No.
Form Name
ABCs Case Report Form
0920-0978
2020 ABC Surveillance Case Report
ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form
0920-0978
ABC H. Influenzae Neonatal Sepsis Expanded Surveillance Form
ABCs Invasive Pneumococcal Disease in Children
0920-0978
ABC Invasive Pneumococcal Disease in Children (age>2 months to <5 years
ABCs Neonatal Infection Expanded Tracking Form
0920-0978
ABC Neonatal Infection Expanded Tracking Form
ABCs Severe GAS Infection Supplemental Form
0920-0978
ABC Severe GAS Infection Supplemental Form
COVID-19 - CDI Case Report and Treatment Form
0920-0978
COVID-19 CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE
COVID-19 - Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form
0920-0978
COVID-19 Invasive Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report – 2020
COVID-19 - Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form
0920-0978
COVID -19 Invasive Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report – 2020
COVID-19 - MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL)
0920-0978
COVID-19 42020 Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae MuGSI-HAIC
COVID-19 - MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB)
0920-0978
COVID-19 - Carbapenem Resistant Enterobacteriaceae (CRE)/ Carbapenem Resistant A. baumannii (CRAB) MUGSI-HAIC
Flu Surv NET Laboratory Survey
0920-0978
FluSurv-NET Laboratory Survey 2019-2020 Season
FoodNet Campylobacter
0920-0978
FoodNet Active Surveillance Variable List
FoodNet Cyclospora
0920-0978
FoodNet Active Surveillance Variable List
FoodNet Hemolytic Uremic Syndrome (HUS)
0920-0978
FoodNet HUS CRF
FoodNet Listeria monocytogenes
0920-0978
FoodNet Active Surveillance Variable List
FoodNet Salmonella
0920-0978
FoodNet Active Surveillance Variable List
FoodNet Shiga toxin producing E. coli
0920-0978
FoodNet Active Surveillance Variable List 2019-2020
FoodNet Shigella
0920-0978
FoodNet Active Surveillance Variable List
FoodNet Vibrio
0920-0978
FoodNet Active Surveillance Variable List
FoodNet Yersinia
0920-0978
Foodborne and DIarrheal Diseases Message Mapping Guide (FDD MMG - FoodNet only portion)
Foodnet Clinical Laboratory Practices and Testing Volume
0920-0978
Foodnet Lab Practices Volume
HAIC CDI Annual Laboratory Survey
0920-0978
Annual Survey of Laboratory Testing Practices for C. difficile Infection
HAIC CDI Annual Surveillance Officers Survey
0920-0978
Surveillance Officer's Survey
HAIC CDI Case Report Form
0920-0978
Clostridioides Difficile Infection (CDI Surveillance Emerging Infections Program Case Report
HAIC CDI LTCF Survey
0920-0978
Emerging Infections Progrom C. difficile Surveillance Nuring Home Telephone Call Survey
HAIC Candidemia Case Report Form
0920-0978
Candidemia 2020 Case Report Form
HAIC Candidemia Periodic Laboratory Survey
0920-0978
2020 Laboratory Testing Practices for Candidemia Questionnaire
HAIC Invasive Methicillin-Sensitive Staphylococcus aureus (MSSA)
0920-0978
Invasive Methicillin-Sensitive Staphylococcus aureau (HAIC) Case Report 2020
HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA)
0920-0978
Invasive Methicillin-Resistant Staphylococcus aureus (MRSA) HAIC Case Report
HAIC Invasive Staphylococcus aureus Annual Laboratory Survey
0920-0978
HAIC Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplificaiton Testing (NAAT)
HAIC Invasive Staphylococcus aureus Annual Surveillance Officers Survey
0920-0978
2019 HAIC Invasive Staphylococcus aureus Supplemental Surveiallance Officer Survey
HAIC Multi-Site Gram-Negative Bacilli Case Report Form (MuGSI-CRE/CRAB)
0920-0978
2020 Carbapenem Resistant Enterobacteriaceae (CRE) Carbapenem Resistant A. baumannii (CRAB) Multi-site Gram-Negative Bacilli Case Report Form (MuGSI-CRE/CRAB)
HAIC Multi-Site Gram-Negative Surveillance Initiative - Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae (MuGSI-ESBL)
0920-0978
2020 Extended-Spectrum Beta-Lactamase (ESBL)- Producting Enterobacteriaceae MuGSI (HAIC)
Influenza Hospitalization Surveilance Network Case Report Form
0920-0978
2019-2020 FluSurv-NET Influenza Hospitalization Surveillance Project Case Report Form
Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)
0920-0978
FluSurv Net Provider Vaccination History Fax Form
Influenza Hospitalization Surveillance Project Vaccination Telephone Script / Consent Form (English)
0920-0978, 0920-0978
FluSurv NET Vaccination Phone Script
,
FluSurv NET Consent From English
Influenza Hospitalization Surveillance Project Vaccination Telephone Script / Consent Form (Spanish)
0920-0978, 0920-0978
FluSurv NET Vaccination Phone Script
,
FluSurv NET Consent Form Spanish
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
99,955
138,735
0
0
-38,780
0
Annual Time Burden (Hours)
39,673
40,816
0
2,089
-3,232
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
Addition of COVID-19 related questions to 0920-0978 EIP Forms results in increased burden hours for some instruments but an overall decrease due to entry error on last submission.
Annual Cost to Federal Government:
$31,091,990
Does this IC contain surveys, censuses, or employ statistical methods?
Yes
Part B of Supporting Statement
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Yes
Agency Contact:
Kevin Joyce 404 639-1944 kdj7@cdc.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
07/29/2020